Guyer William bought CORT
March 2, 2026 · Form 4 insider transaction
Guyer William bought 498 shares of Corcept Therapeutics Incorporated at $35.97 per share, a transaction worth $17.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026.; In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.; Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.